
LTZ Therapeutics
Developer of novel immunotherapies designed to treat patients suffering from cancer and other diseases. The company utilizes reverse translational science and tumor biology combined with machine learn...
Valuation
$0
Share Price
N/A
Total Raised
$87.5M
Last Round
N/A